Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC by Garassino, Marina C., MD, Gadgeel, Shirish, XX, Novello, Silvia, XX, Halmos, Balazs, XX, Felip, Enriqueta, XX, Speranza, Giovanna, XX, Hui, Rina, XX, Garon, Edward B., XX, Horinouchi, Hidehito, XX, Sugawara, Shunichi, XX, Rodriguez-Abreu, Delvys, XX, Reck, Martin, XX, Cristescu, Razvan, XX, Aurora-Garg, Deepti, XX, Loboda, Andrey, XX, Lunceford, Jared, XX, Kobie, Julie, XX, Ayers, Mark, XX, Piperdi, Bilal, XX, Pietanza, M. Catherine, XX, Paz-Ares, Luis, XX

Get full text

Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations by Garassino, Marina C., MD, Oskar, Sabine, PhD, MPH, Arunachalam, Ashwini, MPH, BDS, Zu, Ke, PhD, ScD, MPH, Kao, Yu-Han, PhD, Chen, Cai, PhD, Meng, Weilin, MEng, Pietanza, M. Catherine, MD, Zhao, Bin, MD, Aggarwal, Himani, MPhil, PhD

Get full text

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer... by Garassino, Marina C, MD, Gadgeel, Shirish, MBBS, Esteban, Emilio, MD, Felip, Enriqueta, PhD, Speranza, Giovanna, MD, Domine, Manuel, PhD, Hochmair, Maximilian J, PhD, Powell, Steven, MD, Cheng, Susanna Yee-Shan, MD, Bischoff, Helge G, MD, Peled, Nir, Prof, Reck, Martin, MD, Hui, Rina, PhD, Garon, Edward B, MD, Boyer, Michael, MD, Wei, Ziwen, PhD, Burke, Thomas, PhD, Pietanza, M Catherine, MD, Rodríguez-Abreu, Delvys, MD

Get full text

Response of thymoma to cetuximab by Farina, Gabriella, MD, Garassino, Marina C, Dr, Gambacorta, Marcello, MD, La Verde, Nicla, MD, Gherardi, Giorgio, MD, Scanni, Alberto, MD

Get full text